← Open Payments lookup

KATIE HEBERT: Open Payments

NPI 1942765326 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,553 in 118 payments from 16 companies in 2025. Trend: 2023 $1,801 · 2024 $2,030 · 2025 $2,553

Food & beverage: $2,459Education: $94
CompanyPaymentsAmount
Madrigal Pharmaceuticals21$686
ABBVIE INC.35$581
Gilead Sciences, Inc.11$183
Takeda Pharmaceuticals U.S.A., Inc.13$173
Dexcom, Inc.1$165
Janssen Biotech, Inc.5$151
Phathom Pharmaceuticals, Inc.9$121
GENZYME CORPORATION5$106
GlaxoSmithKline, LLC.1$104
QOL Medical, LLC4$66

Products named: REZDIFFRA, RINVOQ, SKYRIZI, DEXCOM G7 GSS (161), ENTYVIO, TREMFYA, VOQUEZNA, DUPIXENT.

Industry payments across LA — which companies pay providers there.